Methods of stimulating innate immunity using cationic peptides

Details for Australian Patent Application No. 2004271668 (hide)

Owner The University of British Columbia

Inventors Finlay, B Brett; Rosenberger, Carrie Melissa; Scott, Monisha Gough; Powers, Jon-Paul Steven; Hancock, Robert E W; Bowdish, Dawn

Agent Freehills

Pub. Number AU-A-2004271668

PCT Pub. Number WO2005/025607

Priority 10/661,471 12.09.03 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/025607 Priority application(s): WO2005/025607

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271679-Agent containing ergolin for transdermal application

2004271662-Methods for identifying modulators of protein kinase c-epsilon (PKCe) and method of treatment of aberrant glucose metabolism associated therewith